These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37077113)

  • 1. The role of ozone therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19): a review.
    Harapan BN; Harapan T
    Med Gas Res; 2023; 13(4):165-171. PubMed ID: 37077113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience.
    Tascini C; Sermann G; Pagotto A; Sozio E; De Carlo C; Giacinta A; Sbrana F; Ripoli A; Castaldo N; Merelli M; Cadeo B; Macor C; De Monte A
    Intern Emerg Med; 2021 Apr; 16(3):669-675. PubMed ID: 33131033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical effectiveness of medical ozone therapy in COVID-19: the evidence and gaps map.
    Serra MEG; Baeza-Noci J; Abdala CVM; Luvisotto MM; Bertol CD; Anzolin AP
    Med Gas Res; 2023; 13(4):172-180. PubMed ID: 37077114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential therapeutic effect of oxygen-ozone in controlling of COVID-19 disease.
    Yousefi B; Banihashemian SZ; Feyzabadi ZK; Hasanpour S; Kokhaei P; Abdolshahi A; Emadi A; Eslami M
    Med Gas Res; 2022; 12(2):33-40. PubMed ID: 34677149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks.
    Wooding DJ; Bach H
    Clin Microbiol Infect; 2020 Oct; 26(10):1436-1446. PubMed ID: 32791241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CORonavirus-19 mild to moderate pneumonia Management with blood Ozonization in patients with Respiratory failure (CORMOR) multicentric prospective randomized clinical trial.
    Sozio E; De Monte A; Sermann G; Bassi F; Sacchet D; Sbrana F; Ripoli A; Curcio F; Fabris M; Marengo S; Italiani D; Luciana Boccalatte-Rosa D; Tascini C;
    Int Immunopharmacol; 2021 Sep; 98():107874. PubMed ID: 34186281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using Ozone Therapy as an Option for Treatment of COVID-19 Patients: A Scoping Review.
    Radvar S; Karkon-Shayan S; Motamed-Sanaye A; Majidi M; Hajebrahimi S; Taleschian-Tabrizi N; Pashazadeh F; Sahebkar A
    Adv Exp Med Biol; 2021; 1327():151-160. PubMed ID: 34279836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxygen-ozone (O
    Franzini M; Valdenassi L; Ricevuti G; Chirumbolo S; Depfenhart M; Bertossi D; Tirelli U
    Int Immunopharmacol; 2020 Nov; 88():106879. PubMed ID: 32795898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ozone therapy for the treatment of COVID-19 pneumonia: A scoping review.
    Izadi M; Cegolon L; Javanbakht M; Sarafzadeh A; Abolghasemi H; Alishiri G; Zhao S; Einollahi B; Kashaki M; Jonaidi-Jafari N; Asadi M; Jafari R; Fathi S; Nikoueinejad H; Ebrahimi M; Imanizadeh S; Ghazale AH
    Int Immunopharmacol; 2021 Mar; 92():107307. PubMed ID: 33476982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ozone therapy for patients with COVID-19 pneumonia: Preliminary report of a prospective case-control study.
    Hernández A; Viñals M; Pablos A; Vilás F; Papadakos PJ; Wijeysundera DN; Bergese SD; Vives M
    Int Immunopharmacol; 2021 Jan; 90():107261. PubMed ID: 33310665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of current therapeutic options for COVID-19 - lessons to be learnt from SARS and MERS epidemic: A systematic review and meta-analysis.
    Zhong H; Wang Y; Zhang ZL; Liu YX; Le KJ; Cui M; Yu YT; Gu ZC; Gao Y; Lin HW
    Pharmacol Res; 2020 Jul; 157():104872. PubMed ID: 32360583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcome: systematic review.
    Juan J; Gil MM; Rong Z; Zhang Y; Yang H; Poon LC
    Ultrasound Obstet Gynecol; 2020 Jul; 56(1):15-27. PubMed ID: 32430957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of ozone therapy in mild to moderate COVID-19 patients: A phase 1/11 randomized control trial (SEOT study).
    Shah M; Captain J; Vaidya V; Kulkarni A; Valsangkar K; Nair PMK; Ganu G
    Int Immunopharmacol; 2021 Feb; 91():107301. PubMed ID: 33421928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ozone (O3) and SARS-CoV-2: Physiological Bases and Their Therapeutic Possibilities According to COVID-19 Evolutionary Stage.
    Fernández-Cuadros ME; Albaladejo-Florín MJ; Peña-Lora D; Álava-Rabasa S; Pérez-Moro OS
    SN Compr Clin Med; 2020; 2(8):1094-1102. PubMed ID: 32838159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].
    Plaze M; Attali D; Petit AC; Blatzer M; Simon-Loriere E; Vinckier F; Cachia A; Chrétien F; Gaillard R
    Encephale; 2020 Jun; 46(3S):S35-S39. PubMed ID: 32387014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxygen-ozone therapy as adjuvant in the current emergency in SARS-COV-2 infection: a clinical study.
    ; Marini S; Maggiorotti M; Dardes N; Bonetti M; Martinelli M; Re L; Carinci F; Tavera C
    J Biol Regul Homeost Agents; 2020; 34(3):757-766. PubMed ID: 32462858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of coronavirus infection (SARS-CoV-2, MERS-CoV, and SARS-CoV) during pregnancy and the possibility of vertical maternal-fetal transmission: a systematic review and meta-analysis.
    Diriba K; Awulachew E; Getu E
    Eur J Med Res; 2020 Sep; 25(1):39. PubMed ID: 32887660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of severe acute respiratory syndrome coronavirus-2 infectivity by admissible concentration of ozone gas and water.
    Murata T; Komoto S; Iwahori S; Sasaki J; Nishitsuji H; Hasebe T; Hoshinaga K; Yuzawa Y
    Microbiol Immunol; 2021 Jan; 65(1):10-16. PubMed ID: 33230863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.